Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)
Today, Credit Suisse Group reiterated its Hold rating on Ascendis Pharma A/S (NASDAQ:ASND) with a price target of $50.00.
Some recent analyst ratings include
- 3/20/2018-Credit Suisse Group Reiterated Rating of Hold.
- 2/26/2018-Wedbush Reiterated Rating of Outperform.
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 1/17/2018-JPMorgan Chase & Co. Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo Reiterated Rating of Buy.
- 9/1/2017-Leerink Swann Reiterated Rating of Hold.
Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
Shares of Ascendis Pharma A/S closed the previous trading session at 64.90 up +1.89 3.01% with 13662 shares trading hands.